ClinicalTrials.gov
public full text
Public Domain
A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis
The purpose of the study is to examine the safety and effectiveness of sirolimus treatment for people with systemic sclerosis. The investigators perform a multi-centre, double-blind pilot trial with sirolimus in SSc.The investigators evaluate the effectiveness and safeness of sirolimus for Systemic Sclerosis by randomized controlled study (sirolimus 2mg/d (N = 36) versus placebo group (N = 36)).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study#838525
- A pharmacovigilance study of sirolimus-associated adverse events in organ transplantation.#295231
- NeoVas Bioresorbable Coronary Scaffold Registry Study#1125202
- Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients#1103083
- Cardiac Safe Transplants for Systemic Sclerosis#810251
Record · ID 866044
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive